Meanwhile, another bioinformatical study focusing on the m6A regulators in GBM identified that the risk score consists of HNRNPC, ALKBH5 and FTO could predict the survival outcome in GBM patients independently [24]. The gene discussed is FTO; the disease is glioblastoma.